Funding for this research was provided by:
National Heart, Lung, and Blood Institute (U01-HL131003, U01-HL098163, UM1-HL128711, U01-HL098188, UM1-HL098162, UM1-HL098123, U01-HL098153, UM1-HL098147, UM1-HL128761)
National Institute of General Medical Sciences (R01GM120609)
U.S. National Library of Medicine (T15LM007079)
Text and Data Mining valid from 2020-04-29
Received: 9 September 2019
Accepted: 9 April 2020
First Online: 29 April 2020
Ethics approval and consent to participate
: CHD subjects were recruited to the Congenital Heart Disease Network Study of the Pediatric Cardiac Genomics Consortium (CHD GENES: ExternalRef removed identifier NCT01196182). The institutional review boards of Boston’s Children’s Hospital (protocol number 10-08-0404), Brigham and Women’s Hospital (protocol number 2010P002667/PHS), Great Ormond Street Hospital (protocol number REC reference: 10/H0711/98; IRAS project ID: 34974), Children’s Hospital of Los Angeles (protocol number CCI-10-00245), Children’s Hospital of Philadelphia (protocol number 10-007730), Columbia University Medical Center (protocol number AAAF3161), Icahn School of Medicine at Mount Sinai (protocol number HS#: 10-00616; GCO#1: 09-0104(0001) NHLBI/ NIH), Rochester School of Medicine and Dentistry (protocol number RSRB00033081), Steven and Alexandra Cohen Children’s Medical Center of New York (protocol number 10-258A), and Yale School of Medicine (protocol number 1010007481) approved the protocols. All subjects or their parents provided informed consent. Our research conformed to the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.